Bergo MO, Gavino BJ, Hong C, Beigneux AP, McMahon M, Casey PJ, Young SG (2004) Inactivation of Icmt inhibits transformation by oncogenic K-Ras and B-Raf. J Clin Invest 539-550

Bordier BB, Marion PL, Ohashi K, Kay MA, Greenberg HB, Casey JL, Glenn JS (2002) A prenylation inhibitor prevents production of infectious hepatitis delta virus particles. J. Virol 10465-10472 Bordier BB, Ohkanda J, Liu P, Kim SY, Salazar FH, Marion PL, Meuse L, Ohashi K, Kay MA, Casey JL (2003) In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus (HDV). J Clin Invest 407-414 Casey JL (1996) Hepatitis delta virus. Genetics and Pathogenesis. Clinics Lab Med 451-464

Casey JL, Brown TL, Colan EJ, Wignall FS, Gerin JL (1993) A genotype of hepatitis D virus that occurs in northern South America. Proc Natl Acad Sci USA 9016-9020 Casey PJ (1995) Protein lipidation in cell signaling. Science 221-225 Chang F-L, Chen P-J, Tu S-J, Wang C-J, Chen D-S (1991) The large form of hepatitis d antigen is crucial for assembly of hepatitis D virus. Proc Natl Acad Sci USA 8490-8494

Chang J, Sigal LJ, Lerro A, Taylor J (2001) Replication of the human hepatitis delta virus genome Is initiated in mouse hepatocytes following intravenous injection of naked DNA or RNA sequences. J Virol 3469-3473 Chang M-F, Chang SC, Chang C-I, Wu K, Kang H-Y (1992) Nuclear localization signals, but not putative leucine zipper motifs, are essential for nuclear transport of hepatitis delta antigen. J Virol 6019-6027 Chao M, Hsieh S-Y, Taylor J (1990) Role of two forms of hepatitis delta virus antigen: evidence for a mechanism of self-limiting genome replication. J Virol 5066-5069 Chen P-J, Chang F-L, Wang C-J, Lin C-J, Sung S-Y, Chen D-S (1992) Functional study of hepatitis delta virus large antigen in packaging and replication inhibition: Role of the amino-terminal leucine zipper. J Virol 2853-2859 Chou H-C, Hsieh T-Y, Sheu G-T, Lai MMC (1998) Hepatitis delta antigen mediates the nuclear import of hepatitis delta virus RNA. J Virol 3684-3690 Cirelli R, Herne K, McCrary M, Lee P, Tyring SK (1996) Famciclovir: review of clinical efficacy and safety. Antiviral Res 141-151 Dalton MB, Fantle KS, Bechtold HA, DeMaio L, Evans RM, Krystosek A, Sinensky M (1995) The farnesyl protein transferase inhibitor BZA-5B blocks farnesylation of nuclear lamins and p21ras but does not affect their function or localization. Cancer Res 3295-3304 Elazar M, Glenn JS (2005) Confronting new and old antiviral threats: broad spectrum potential of prenylation inhibitors. In: Torrence PF, ed. Antiviral drug discovery for emerging diseases and bioterrorism threats: John Wiley & Sons, Inc. pp 249261

Farassati F, Yang AD, Lee PW (2001) Oncogenes in Ras signalling pathway dictate host-cell permissiveness to herpes simplex virus 1. Nat Cell Biol 745-750 Farci P, Mandas A, Coiana A, Lai ME, Desmet V, Van Eyken P, Gibo Y, Caruso L, Scaccabarozzi S, Criscuolo D and others (1994) Treatment of chronic hepatitis D with interferon alfa-2a. New Engl J Med 88-94

Farci P, Roskams T, Chessa L, Peddis G, Mazzoleni AP, Scioscia R, Serra G, Lai ME, Loy M, Caruso L, et al. (2004) Long-term benefit of interferon alpha therapy of chronic hepatitis D: regression of advanced hepatic fibrosis. Gastroenterology 1740-1749

Farnsworth CC, Gelb MH, Glomset JA (1990) Identification of geranylgeranyl-modified proteins in HeLa cells. Science 320-322 Farnsworth CC, Wolda SL, Gelb MH, Glomset JA (1989) Human lamin B contains a farnesylated cysteine residue. J Biol Chem 20422-20429 Gerin JL, Casey JL, Purcell RH (2001) Hepatitis delta virus. In: Howley PM, ed. Fields virology. Philadelphia: Lippincot & Wilkins. pp 3037-3050 Glenn JS (1999) Shutting the door on hepatitis delta virus (HDV): Sensitivity to prenylation inhibition prompts new therapeutic strategy. Viral Hepatitis Reviews 5:13-26

Glenn JS, Marsters Jr. JC, Greenberg HB (1998) Use of a prenylation inhibitor as a novel antiviral agent. J Virol 9303-9306 Glenn JS, Watson JA, Havel CM, White JM (1992) Identification of a prenylation site in delta virus large antigen. Science 1331-1333 Glenn JS, White JM (1991) Trans-dominant inhibition of human hepatitis delta virus genome replication. J Virol 2357-2361 Gower TL, Graham BS (2001) Antiviral activity of lovastatin against respiratory syn-

cytial virus in vivo and in vitro. Antimicrob Agents Chemother 1231-1237 Hancock JF, Cadwallader K, Marshall CJ (1991) Methylation and proteolysis are essential for efficient membrane binding of prenylated p21K-ras(B). EMBO J 641-646 Hancock JF, Magee AI, Childs JE, Marshall CJ (1989) All ras proteins are polyisopreny-

latedbut only some are palmitoylated. Cell 1167-1177 Hoffman GR, Nassar N, Cerione RA (2000) Structure of the Rho family GTP-binding protein Cdc42 in complex with the multifunctional regulator RhoGDI. Cell 345356

Hoofnagle JH (1989) Type D (delta) hepatitis. JAMA 1321-1325 Hwang SB, Lai MMC (1993) Isoprenylation mediates direct protein-protein interactions between hepatitis large delta antigen and hepatitis B virus surface antigen. J Virol 7659-7662

Hwang SB, Lee C-Z, Lai MMC (1992) Hepatitis delta antigen expressed by recombinant baculoviruses: Comparison of biochemical properties and post-translational modifications between the large and small forms. Virology 413-422 Jabbour E, Kantarjian H, Cortes J (2004) Clinical activity of farnesyl transferase inhibitors in hematologic malignancies: possible mechanisms of action. Leuk Lymphoma 2187-2195

James GL, Brown MS, Cobb MH, Goldstein JL (1994) Benzodiazepine peptidomimetic BZA-5B interrupts the MAP kinase activation pathway in H-Ras-transformed Rat-1 cells, but not in untransformed cells. J Biol Chem 27705-27714 James GL, Goldstein JL, Brown MS, Rawson TE, Somers TC, McDowell RS, Crowley CW, Lucas BK, Levinson AD, Marsters JCJ (1993) Benzodiazepine peptidomimetics: Potent inhibitors of ras farnesylation in animal cells. Science 1937-1942 Kapadia SB, Chisari FV (2005) Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids. Proc Natl Acad Sci USA 2561-2566

Kim E, Ambroziak P, Otto JC, Taylor B, Ashby M, Shannon K, Casey PJ, Young SG (1999) Disruption of the mouse Reel gene results in defective Ras processing and mislocalization of Ras within cells. J Biol Chem 8383-8390 Lau D, Doo E, Park Y, Kleiner D, Schmid P, Kuhns M, Hoofnagle J (1999) Lamivudine for chronic delta hepatitis. Hepatology 546-549 Lazinski DW, Taylor JM (1993) Relating structure to function in the hepatitis delta virus antigen. J Virol 2672-2680 LiuM, Bryant MS, Chen J, Lee S, Yaremko B, al. e (1999) Effects of SCH 59228, an orally bioavailable farnesyl protein transferase inhibitor, on the growth of oncogene-transformed fibroblasts and a human colon carcinoma xenograft in nude mice. Cancer Chemother Pharmacol 50-58 Maltese WA (1990) Posttranslational modification of proteins by isoprenoids in mammalian cells. FASEB J 3319-3328 Mazieres J, Pradines A, Favre G (2004) Perspectives on farnesyl transferase inhibitors in cancer therapy. Cancer Lett 159-167 McGeoch DJ, Dalrymple MA, Davison AJ, Dolan A, Frame MC, McNab D, Perry LJ, Scott JE, Taylor P (1988) The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1. J Gen Virol 1531-1574 Novick P, Brennwald P (1993) Friends and family: The role of the Rab GTPases in vesicular traffic. Cell 597-601 Otto JC, Casey PJ (1996) The hepatitis delta virus large antigen is farnesylated both in vitro and in animal cells. J Biol Chem 4569-4572 Parish CA, Rando RR (1996) Isoprenylation/methylation of proteins enhances membrane association by a hydrophobic mechanism. Biochemistry 8473-8477 Pereira-Leal JB, Seabra MC (2001) Evolution of the Rab family of small GTP-binding proteins. J Mol Biol 889-901 Pfeffer S, Aivazian D (2004) Targeting Rab GTPases to distinct membrane compartments. Nat Rev Mol Cell Biol 886-896 Pullarkat RK, Morris GN (1997) Farnesylation of Batten disease CLN3 protein. Neu-ropediatrics 42-44

Radjef N, Gordien E, Ivaniushina V, Gault E, Anais P, Drugan T, Trinchet JC, Roulot D, Tamby M, Milinkovitch MC and others (2004) Molecular phylogenetic analyses indicate a wide and ancient radiation of African hepatitis delta virus, suggesting a deltavirus genus of at least seven major clades. J Virol 2537-2544 Rizzetto M, Ponzetto A, Forzani I (1991) Epidemiology of hepatitis delta virus: Overview. In: Rizetto M, editor. The hepatitis delta virus. New York: Wiley-Liss Inc. pp 1-20

Rowinsky EK, Windle JJ, Von Hoff DD (1999) Ras protein farnesyltransferase: A strategic target for anticancer therapeutic development. J Clin Oncol 3631-3652 Ryu W-S, Bayer M, Taylor J (1992) Assembly of hepatitis delta virus particles. J Virol 2310-2315

Samuel D, Zignego A-L, Reynes M, Feray C, Arulnaden JL, David M-F, Gigou M, Bismuth A, Mathieu D, Gentilini P and others (1995) Long-term clinical and virological outcome after liver transplantation for cirrhosis caused by chronic delta hepatitis. Hepatology pp 333-339

Sato S, Cornillez-Ty C, Lazinski DW (2004) By inhibiting replication, the large hepatitis delta antigen can indirectly regulate amber/W editing and its own expression. J Virol 8120-8134

Sebti SM, Hamilton AD (2000) Farnesyltransferase and geranylgeranyltransferase I inhibitors and cancer therapy: lessons from mechanism and bench-to-bedside translational studies. Oncogene 6584-6593 Sharma S, Kemeny N, Kelsen DP, Ilson D, O'Reilly E, Zaknoen S, Baum C, Statkevich P, Hollywood E, Zhu Y, et al. (2002) A phase II trial of farnesyl protein transferase inhibitor SCH 66336, given by twice-daily oral administration, in patients with metastatic colorectal cancer refractory to 5-fluorouracil and irinotecan. Ann Oncol 1067-1071

Shih KN, Lo SJ (2001) The HDV large-delta antigen fused with GFP remains functional and provides for studying its dynamic distribution. Virology 138-152 Silvius JR, l'Heureux F (1994) Fluorimetric evaluation of the affinities of isoprenylated peptides for lipid bilayers. Biochemistry 3014-3022 Sinensky M, Beck LA, Leonard S, Evans R (1990) Differential inhibitory effects of lovastatin on protein isoprenylation and sterol synthesis. J Biol Chem 1993719941

Sun J, Qian Y, Hamilton AD, Sebti SM (1995) Ras CAAX peptidomimetic FTI 276 selectively blocks tumor growth in nude mice of a human lung carcinoma with K-Ras mutation and p53 deletion. Cancer Res 4243-4247 Sureau C, Guerra B, Lanford RE (1993) Role of the large hepatitis B virus envelope protein in infectivity of the hepatitis delta virion. J Virol 366-372 Sureau C, Moriarty AM, Thornton GB, Lanford RE (1992) Production of infectious hepatitis delta virus in vitro and neutralization with antibodies directed against hepatitis B virus pre-S antigens. J Virol 1241-1245 Wei Y, Ganem D (1998) Activation of heterologous gene expression by the large isoform of hepatitis delta virus. J Virol 2089-2096 Winter-Vann AM, Baron RA, Wong W, dela Cruz J, York JD, Gooden DM, Bergo MO, Young SG, Toone EJ, Casey PJ (2005) A small-molecule inhibitor of isoprenyl-cysteine carboxyl methyltransferase with antitumor activity in cancer cells. Proc Natl Acad Sci USA 4336-4341 Winter-Vann AM, Casey PJ (2005) Opinion: Post-prenylation-processing enzymes as new targets in oncogenesis. Nat Rev Cancer 405-412 Wolters LM, van Nunen AB, Honkoop P, Vossen AC, Niesters HG, Zondervan PE, de Man RA (2000) Lamivudine-high dose interferon combination therapy for chronic hepatitis B patients co-infected with the hepatitis D virus. J Viral Hepat 428-434

Xia Y-P, Yey C, Ou J-S, Lai MMC (1992) Characterization of nuclear targeting signal of hepatitis delta antigen: Nuclear transport as a protein complex. J Virol 914-921 Yamane HK, Farnsworth CC, Xie H, Howald W, Fung BK-K, Clarke S, Gelb MH, Glomset JA (1990) Brain G protein g subunits contain an all-trans-geranylgeranyl-cysteine methyl ester at their carboxyl termini. Proc Natl Acad Sci USA 5868-5872 Ye J, Wang C, Sumpter R, Jr., Brown MS, Goldstein JL, Gale M, Jr. (2003) Disruption of hepatitis C virus RNA replication through inhibition of host protein geranylger-anylation. Proc Natl Acad Sci USA 15865-15870

Yurdaydin C, Bozkaya H, Gurel S, Tillmann HL, Asian N, Okcu-Heper A, Erden E, Yalcin K, Iliman N, Uzunalimoglu O and others (2002) Famciclovir treatment of chronic delta hepatitis. J Hepatol 266-271 Zhang FL, Casey PJ (1996) Protein prenylation: Molecular mechanisms and functional consequences. Annu Rev Biochem 241-269 Zignego AL, Samuel D, Gentilini P, Bismuth H (1993) Patterns and mechanisms of hepatitis B/hepatitis D reinfection after liver transplantation. Arch Virol Suppl 281-289

CTMI (2006) 307:151-171 © Springer-Verlag Berlin Heidelberg 2006

10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook

Post a comment